Search All News
Anil K. Rustgi, MD, an expert in gastrointestinal tumors, will join Columbia University Irving Medical Center and NewYork-Presbyterian as director of the Herbert Irving Comprehensive Cancer Center.
A new study suggests that a type of brain tumor in patients with neurofibromatosis type 1 could be treated with immunotherapy, which has so far proved ineffective in treating most brain cancers.
A new study found that women with cervical cancer who had a radical hysterectomy with minimally invasive surgery had a significantly higher risk of death than those who had open surgery.
For the second year, Velocity, Columbia's Ride to End Cancer raised more than $1 million for cancer care and research.
- December 5, 2016
In a phase 1 study, eight out of 12 patients with relapsed and/or refractory blood cancers responded to a combination of two common chemotherapy drugs.
- September 14, 2016
In mice studies, targeting the SET protein revives p53, a potent tumor suppressor, and prevents cancer growth.
- July 21, 2016
Adding a new drug called olaratumab to traditional chemotherapy increased survival in sarcoma patients, researchers at Columbia University Medical Center have found.
- July 15, 2016
The three-dimensional structure could help researchers develop novel therapies and diagnostic tools for diseases that are caused by a malfunction in calcium adsorption.
- July 12, 2016
According to a new report published in JAMA Oncology, women with BRCA1 mutations have a higher risk of developing an aggressive type of uterine cancer.
- July 8, 2016
$4 million grant gives Columbia, Weill Cornell Medicine, NewYork-Presbyterian, and NYC Health + Hospitals key role in precision medicine cohort program.
- July 1, 2016
CUMC, NYP, and Weill Cornell are participating in a care delivery model that supports and encourages higher quality, more coordinated cancer care.
Source:New York TimesJune 23, 2016